http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010511877-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010511877-A |
| titleOfInvention | Diagnosis and risk stratification of cardiac dysfunction using neurophysin |
| abstract | The present invention relates to a method for diagnosing cardiac dysfunction and / or stratification of risk, wherein the measurement of the marker neurophysin or a fragment or partial peptide thereof is performed on the patient to be tested. Is called. The present invention relates to advantageous marker combinations, including neurophysin. Furthermore, the present invention relates to a diagnostic device and a kit for performing the method. In one embodiment, the methods of the invention can be performed in vitro. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014519609-A |
| priorityDate | 2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.